D. Kuroki

发表

Regulation of a c-Jun Amino-terminal Kinase/Stress-activated Protein Kinase Cascade by a Sodium-dependent Signal Transduction Pathway*

A. Minden, E. Wattenberg, D. Kuroki, 1997, The Journal of Biological Chemistry.

A Bispecific Recombinant Immunotoxin, DT2219, Targeting Human CD19 and CD22 Receptors in a Mouse Xenograft Model of B-Cell Leukemia/Lymphoma

D. Vallera, D. Todhunter, A. Sicheneder, 2005, Clinical Cancer Research.

ABispecific Recombinant Immunotoxin , DT 2219 , Targeting Human CD 19 and CD 22 Receptors in aMouse XenograftModel of B-Cell Leukemia / Lymphoma

D. Vallera, D. Todhunter, A. Sicheneder, 2005 .

Radiotherapy of CD19 expressing Daudi tumors in nude mice with Yttrium-90-labeled anti-CD19 antibody.

M. Brechbiel, J. Wagner, K. Dusenbery, 2004, Cancer biotherapy & radiopharmaceuticals.

Activation of stress-activator protein kinase/c-Jun N-terminal kinase by the non-TPA-type tumor promoter palytoxin.

E. Wattenberg, G. Bignami, D. Kuroki, 1996, Cancer research.

Preclinical studies targeting normal and leukemic hematopoietic cells with Yttrium-90-labeled anti-CD45 antibody in vitro and in vivo in nude mice.

M. Brechbiel, J. Wagner, K. Dusenbery, 2003, Cancer biotherapy & radiopharmaceuticals.

Molecular modification of a recombinant, bivalent anti-human CD3 immunotoxin (Bic3) results in reduced in vivo toxicity in mice.

D. Vallera, D. Todhunter, Vincent D. Vallera, 2005, Leukemia research.

Bovine herpesvirus 1 glycoprotein G is required for prevention of apoptosis and efficient viral growth in rabbit kidney cells.

Y. Matsumoto, H. Otsuka, D. Kuroki, 2001, Virology.

Bovine herpesvirus 1 glycoprotein G is required for viral growth by cell-to-cell infection.

H. Otsuka, K. Ôhara, D. Kuroki, 2000, Virus research.

Molecular modification of a recombinant anti-CD3epsilon-directed immunotoxin by inducing terminal cysteine bridging enhances anti-GVHD efficacy and reduces organ toxicity in a lethal murine model.

B. Blazar, D. Vallera, D. Buchsbaum, 2000, Blood.